lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway-Reference-Cited by-同舟云学术

lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway

Published:2021-06-10 Issue:12 Volume:20 Page:1147-1162
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Zhao Qing¹,Dong Dandan¹,Chu Huihui¹,Man Lu¹,Huang Xinhe¹,Yin Li¹,Zhao Di¹,Mu Lin¹,Gao Ce¹,Che Jianhua¹,Liu Qian¹

Affiliation:

1. Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

Funder

National Natural Science Youth Foundation of China

Natural Science Foundation of Heilongjiang Province of China

Postdoctoral Science Foundation of Heilongjiang Province of China

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2021.1924947

Reference26 articles.

1. Global cancer statistics

2. Epithelial Ovarian Cancer

3. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer

4. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer

5. miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A circadian rhythm-related lncRNA signature correlates with prognosis and tumor immune microenvironment in head and neck squamous cell carcinoma;Discover Oncology;2024-07-25

2. Baicalin Prevents Colon Cancer by Suppressing CDKN2A Protein Expression;Chinese Journal of Integrative Medicine;2024-06-28

3. A cuproptosis-related lncRNA signature predicts the prognosis and immune cell status in head and neck squamous cell carcinoma;Frontiers in Oncology;2023-07-19

4. Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach;Thoracic Cancer;2023-04-19

5. Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma;Biotechnology and Genetic Engineering Reviews;2023-03-23